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Abstract: The aim of this study was to isolate the antimicrobial-resistant enterobacteria from cattle feces and to identify the extendedspectrum beta-lactamase (ESBL) and carbapenemase gene among them. A total of 70 cattle fecal swab samples were collected from
Durg, Chhattisgarh, India, and cultured in nutrient broth. Bacterial isolation recovered 120 gram-negative bacteria. Antimicrobial
susceptibility testing showed 90 (75%) coliform isolates (66 Escherichia coli, 20 Klebsiella sp., and two each of Enterobacter sp. and
Citrobacter sp.) resistant to amoxicillin, amoxicillin-clavulanic acid, cefixime, ceftazidime, imipenem, or meropenem. Bacterial isolates
showed the highest resistance rate for ceftazidime (61.6%), followed by cefixime and amoxicillin-clavulanic acid (60%). The ESBL
phenotype, assessed by combination disk method, was shown by 36 (40%) of the resistant isolates. PCR amplification revealed 20%
and 31.6% positivity of blaTEM and blaSHV genes, respectively. blaTEM and blaSHV coexpression was recorded among eight (12.1%) E. coli
and two (10%) Klebsiella sp. isolates. Restriction endonuclease analysis indicated clonal blaTEM and clonal and nonclonal blaSHV genes.
Nucleotide sequencing confirmed the blaTEM and blaSHV genotypes. None of the isolates showed amplification of the carbapenemase
gene. Phenotypic and genetic detection and characterization of ESBLs among Enterobacteriaceae bacteria illustrate the importance of
planning and execution of effective control programs for emerging antimicrobial-resistant pathogens.
Key words: Beta-lactam resistance, cattle, coliform, Enterobacteriaceae, extended-spectrum beta-lactamase

1. Introduction
One of the most important mechanisms for development
of antimicrobial resistance of bacteria is mediated by
the production of bacterial beta-lactamases. Extendedspectrum beta-lactamases (ESBLs) are capable of
targeting a broader spectrum of antibiotics, including
penicillins and their complexes, monobactams, and up
to third-generation cephalosporins (1). Members of
Enterobacteriaceae are commensals in the intestines of
animals and are usually under selective pressure by use
of antibiotics for treatment and prevention of infectious
diseases (2). Furthermore, Escherichia coli and Klebsiella
pneumoniae expressing ESBLs in particular are
important microbial pathogens that have been reported
more frequently in association with the acquisition
and transmission of drug-resistance elements (3,4).
There are limited reports on beta-lactam-resistant

enterobacteria related to livestock animals from India.
Therefore, the present study was planned to isolate the
bovine fecal enterobacteria and to characterize them
on the basis of beta-lactam resistance. Isolation of
antimicrobial-resistant bacteria from animal sources
indicates their possible spread into the environment
and/or human populations. ESBL genes can be
transferred from nondisease-causing bacteria to those
that cause disease. Surveillance of these genes could
be a valuable tool to screen the resistance trends at a
population level (5). The emergence of antimicrobial
resistance is usually assessed either by population
analysis or susceptibility testing of bacteria (6). Advance
drug resistance surveillance and knowledge of the
molecular characteristics of ESBL-producing isolates
are necessary to guide the appropriate and judicious use
of antibiotics (7).
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2. Materials and methods
2.1. Collection and transportation of samples
A total of 70 fecal swab samples were collected randomly
from farmed dairy cows reared in semiorganized herds in
the Durg district of the Chhattisgarh state of India during
the monsoon season of 2014. All the fecal samples were
collected in screw-capped sterile specimen containers and
immediately transported to the laboratory for isolation of
bacteria.
2.2. Bacterial isolation and identification
Each of the fecal swab samples was separately inoculated
into 10 mL of nutrient broth and incubated at 37 °C for 24
h. The broth cultures were streaked onto MacConkey agar
(HiMedia Pvt. Ltd., Mumbai, India) and further incubated
at 37 °C for 18–24 h to isolate the enterobacteria. Bacterial
colonies were screened based on morphological features.
Each of the distinct colonies was considered as one
isolate and maintained in a pure culture slant. Bacterial
identification was done by cultural and biochemical tests
following indole, methyl red, Voges–Proskauer, and citrate
utilization tests and urease test and H2S production on
triple sugar iron agar (8).
2.3. Antimicrobial susceptibility testing (AST)
AST of bacterial isolates was performed following the disk
diffusion method using amoxicillin (30 µg), amoxicillinclavulanic acid (30 µg), ceftazidime (30 µg), cefixime (5
µg), imipenem (10 µg), and meropenem (10 µg) disks
(HiMedia Pvt. Ltd.) (9). The procedure was optimized
against Escherichia coli ATCC 25922.
2.4. Phenotypic tests for ESBLs and carbapenemases
A combination disk method was used for phenotypic
detection of ESBL production by bacteria as per CLSI
guidelines (9). The test was performed on Mueller–
Hinton agar (HiMedia Pvt. Ltd.) petri plates using disks
of extended-spectrum cephalosporins like ceftazidime (30
µg) alone and in combination with clavulanic acid (10 µg).
A ≥5-mm increase in zone diameter for ceftazidime tested

in combination with clavulanic acid versus its zone when
tested alone was considered as confirmatory for ESBL
production.
The modified Hodge test was performed for phenotypic
assessment of carbapenemase production by carbapenemresistant enterobacteria (9). Klebsiella pneumoniae BAA
1705 (KPC-positive) and Klebsiella pneumoniae BAA 1706
(KPC-negative) were used as quality control organisms.
The Escherichia coli ATCC 25922 strain was used as an
indicator organism with a meropenem disk (10 µg) to
perform this test.
2.5. Isolation of plasmid DNA
The resistant bacterial isolates were streaked onto
MacConkey agar to get a pure colony. A single colony of
each isolate was inoculated into 10 mL of Luria–Bertani
(LB) broth medium (HiMedia Pvt. Ltd.) kept in 50-mL
tubes and incubated at 37 °C for 12–15 h in an incubator
shaker. The pellet was prepared by centrifuging the
bacterial suspension at 10,000 × g for 3 min. Plasmid
DNA was isolated using the GeneJet Plasmid Miniprep kit
(Thermo Fisher Scientific, Waltham, MA, USA) and used
for detection of antimicrobial resistance genes.
2.6. Polymerase chain reaction (PCR)
PCR amplification was performed in a thermal cycler
(Eppendorf, Hamburg, Germany) using specific primers
(Sigma Aldrich, St. Louis, MO, USA) (Table) to detect the
blaTEM (10), blaSHV (11), blaKPC, and blaNDM (12) genes. The
PCR reaction mixtures and amplification conditions were
optimized for all genes. The blaTEM-positive Escherichia
coli (maintained at the laboratory), Klebsiella pneumoniae
ATCC 700603, Klebsiella pneumoniae ATCC BAA-1705,
and blaNDM-positive Shigella sp. isolate (accession number
KR872630.1) were used as positive controls for the blaTEM,
blaSHV, blaKPC, and blaNDM genes, respectively. Escherichia
coli ATCC 25922 was used as a negative control for all the
target genes. PCR amplification was carried out using 25µL reactions containing 200 µM of dNTPs, 0.2 µM of each
primer, 1.25 U of Taq DNA polymerase (Sigma Aldrich),

Table. Primer pairs used for amplification of beta-lactamase genes.
Genes
blaTEM
blaSHV
blaKPC
blaNDM
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Primers
F- 5’AAAATTCTTGAAGACG 3’
R- 5’ TTACCAATGCTTAATCA 3’
F- 5’TCAGCGAAAAACACCTTG 3’
R- 5’TCCCGCAGATAAATCACC 3’
F-5’CATTCAAGGGCTTTCTTGCTGC 3’
R- 5’ACGACGGCATAGTCATTTGC 3’
F- 5’GGTTTGGCGATCTGGTTTTC 3`
R- 5’CGGAATGGCTCATCACGATC 3`

Amplicon size

Reference

1073 bp

10

472 bp

11

538 bp
12
621 bp
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and 1.875 mM of MgCl2 in 1X PCR buffer. About 50 ng
of DNA was used as a template. The components of the
PCR reaction mixture except MgCl2 (1.25 mM) for blaKPC
and blaNDM genes were similar to those for the blaTEM and
blaSHV genes. The cycling conditions comprised initial
denaturation at 94 °C for 3 min followed by 35 cycles
each of denaturation at 94 °C for 30 s, annealing at 50
°C for 30 s, and extension at 72 °C for 2 min, with a final
extension at 72 °C for 10 min, for the amplification of
the blaTEM and blaSHV genes. For the amplification of the
blaKPC and blaNDM genes the cycling conditions comprised
initial denaturation at 94 °C for 5 min followed by 39
cycles each of denaturation at 94 °C for 45 s, annealing at
52 °C for 1 min, and extension at 72 °C for 1 min with
final extension at 72 °C for 10 min. The amplified PCR
products (5 µL) were separated using 1.5% agarose gel
stained with ethidium bromide (0.5 µg/mL) by running
them in a horizontal submarine electrophoresis unit using
1X TAE as the running buffer and examined under the gel
documentation system (Thermo Fisher Scientific).
2.7. Restriction endonuclease (RE) analyses
PCR-amplified blaTEM and blaSHV gene products were
digested with PstI and AvaII endonucleases (Thermo
Fisher Scientific) as per the previously reported method
(10) with slight modifications. For RE analyses, the PCR
products (5 µL) were mixed with 0.5 µL of RE and 2 µL
of 10X buffer. The final volume of 20 µL was made up
with nuclease-free water. The reaction mixture was spun
in a microcentrifuge and incubated at 37 °C for 18 h in a
dry bath. The restriction digested products (10 µL) were
separated using 2% agarose (Sigma Aldrich) gel stained
with ethidium bromide (0.5 µg/mL).
2.8. Gene cloning and sequencing
Plasmid DNA samples representing the blaTEM and
blaSHV genes were amplified by Pfu DNA polymerase
(Thermo Fisher Scientific). The gene products in excised
gels were purified by the GeneJET PCR Purification Kit
(Thermo Fisher Scientific), eluted in 25 µL of elution
buffer, and ligated into a pJET 1.2/blunt cloning vector
(50 ng) provided with the CloneJET PCR Cloning Kit
(Thermo Fisher Scientific). The ligation mixture was
incubated at room temperature (22 °C) for 30 min and
used directly to transform the E. coli (DH5α). Rapid
preparation of chemically competent cells was done using
the TransformAid Bacterial Transformation Kit (Thermo
Fisher Scientific). The competent cell suspension was
plated immediately on prewarmed LB agar (HiMedia Pvt.
Ltd.) plates containing 50 µg/mL ampicillin. Plates were
incubated overnight at 37 °C in an upside-down position
for development of transformant colonies. Colony PCR
was performed to screen the positive transformants. Genespecific colonies were selected and grown further overnight
in LB broth containing 50 µg/mL ampicillin. Plasmid DNA

was further isolated and used for bidirectional nucleotide
sequencing with customized Sanger sequencing (GeNei
Laboratories Pvt. Ltd., Bangalore, India).
3. Results
A total of 120 isolates were recovered from the 70 fecal
swab samples. Isolates were preliminary identified based
on cultural characteristics. All the pure isolate slants were
kept at 4 °C for further study. Out of 120 bacterial isolates
tested by AST, 90 (75%) isolates were identified as resistant
(to amoxicillin, amoxicillin-clavulanic acid, cefixime,
ceftazidime, imipenem, and/or meropenem). The isolates
showed the highest rate of resistance to ceftazidime
(61.6%), followed by cefixime and amoxicillin-clavulanic
acid (60%) (Figure 1). The least resistance was recorded
against imipenem (6.6%). Identification revealed 66
(55%) E. coli, 20 (16.6%) Klebsiella spp., and two each
of Enterobacter sp. and Citrobacter sp. isolates based on
cultural and biochemical characteristics. Out of the 90
resistant isolates, 22 isolates showed beta-lactamasepositive phenotypic test results with amoxicillin and
amoxicillin-clavulanic acid. Twenty-eight isolates showed
ESBL-positive phenotypic test results with ceftazidime and
ceftazidime-clavulanic acid (Figure 2), while eight isolates
developed positive combination disk test results with
both of the combinations (amoxicillin and amoxicillinclavulanic acid, and ceftazidime and ceftazidime-clavulanic
acid). Thus, a total of 36 (28 + 8) isolates expressed the
ESBL phenotype.
Bacterial isolates showed variability in number (1
to 5) and size (1 kb to >21 kb) of plasmids. The size of
most of the plasmids ranged from 2 kb to 20 kb. However,
plasmids of more than 21 kb were also recorded (Figure 3).
Furthermore, some bacterial isolates were found to harbor
plasmids of similar profiles. PCR amplification showed
specific detection of blaTEM (1073 bp) (Figure 4) and blaSHV
(472 bp) genes (Figure 5). Overall positivity of the blaSHV
gene was higher (31.6%) than that of the blaTEM gene (20%).
The blaTEM gene was harbored by 20 (30.3%) E. coli and 4
(20%) Klebsiella sp., whereas the blaSHV gene was shown
by 24 (36.6%) E. coli and 14 (70%) Klebsiella sp. isolates.
Coexpression of the blaTEM and blaSHV genes was recorded
among eight (12.1%) E. coli and two (10%) Klebsiella sp.
isolates. None of the isolates showed detection of the
carbapenemase gene (blaKPC or blaNDM).
RE analysis with PstI digestion of the blaTEM product
(1073 bp) showed uniform fragments of 758 bp and 315 bp
(Figure 6A). The RE pattern of the blaTEM gene by double
site cutter AvaII showed a uniform pattern of fragments of
636 bp, 222 bp, and 215 bp (Figure 6B). PstI digestion of
the blaSHV gene (472 bp) recorded a common pattern (304
bp and 168 bp) (Figure 7A), except for two PCR products
that revealed intact bands. Again, the RE analysis of the
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Figure 1. Antimicrobial resistance pattern of bacterial isolates.

number AF188200.1). In relation to the reference strain
(accession number AF188200.1), nucleotide substitutions
in the blaTEM gene sequence did not alter the amino acid
sequence of the expected translated product (287 amino
acids).

Figure 2. The phenotypic expression of ESBL using combination
disk method.

blaSHV gene by AvaII reflected the uniform band pattern of
DNA fragments of 330 bp and 142 bp (Figure 7B).
Gene sequencing confirmed the blaTEM-1 subtype of
blaTEM (accession number MF346734) and the blaSHV
(accession number MF346732) ESBL genes. Single
nucleotide substitutions of T in place of C (T/C) at
position 18, A/G at position 138, T/G at position 396, T/C
at position 474, and G/A at 717 position were recorded in
blaTEM-harboring isolates with respect to the E. coli betalactamase variant TEM-1D (blaTEM-1D) gene (accession
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4. Discussion
The Enterobacteriaceae are inhabitants of the alimentary
tracts of animals and humans and are shed along with
the feces into the environment, where they may act as
potential threats to public health. Beta-lactam resistance
in the present study was recorded among the isolates of the
coliform group (Escherichia coli, Klebsiella, Enterobacter,
and Citrobacter) of Enterobacteriaceae. Reduced bacterial
susceptibility to advanced antimicrobials, namely the
carbapenems and the third-generation cephalosporins,
may further enhance the uncontrolled spread of these
resistant pathogens at the animal–environment–human
interface. One of the driving forces behind increased betalactam resistance among the Enterobacteriaceae is the use
of third- and fourth-generation cephalosporins (13,14).
Furthermore, the conjugative nature of enterobacteria
facilitates the transfer of beta-lactamase genes from
resistant donors to susceptible bacteria.
The present study corroborated the previous reports
on ESBL-producing Enterobacteriaceae from bovines in
France (15), Switzerland (16,17), the Netherlands (18),
Germany (19), and Nigeria (20). There have only been a
few reports describing the prevalence and characteristics
of ESBL-producing Enterobacteriaceae in healthy farm
animals worldwide. To date, no prevalence data are
available on ESBL-producing Enterobacteriaceae from
cattle in India. However, a negative correlation between
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Figure 3. Bacterial plasmids showing variability in number and size. Lane M: EcoRI +
HindIII DNA marker. Lanes 2, 3, 4, 7, 9–14: Visible plasmids. Lanes 1, 5, 8: No visible
plasmids.

Figure 4. Amplification of full coding region of blaTEM gene(1073 bp). Lane M: EcoRI + HindIII DNA marker. Lanes
1, 3, 4, 6, 9, 10: Test positive. Lanes 2, 5, 7, 8: Test negative. Lane 11: Negative control. Lane 12: Positive control.

possession of ESBL genes and Shiga toxin genes in E. coli
isolated from healthy buffalo was reported (21). Moreover,
a positive correlation between ESBL genes and other
virulence genes (Shiga toxins) was recorded among E. coli
strains isolated from diarrheic piglets in the Mizoram state
of India (22).

The resistance rate of 61.6% to ceftazidime among
ESBL producers in the present study was contrary to a
previous study that reported a resistance rate of 4.2% to
ceftazidime (17). This variation in the resistance rate of
bacteria of different locations might indicate different
selective pressures on the use of selectively different
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Figure 5. Amplification of blaSHV gene(472 bp). Lane M: 50-bp DNA Ladder. Lanes 1, 3, 5:
Test positive. Lane 2: Test negative. Lane 4: Nonspecific. Lane 6: Negative control. Lane 7:
Positive control.

Figure 6. A) RE analysis of blaTEM by PstI. Lane M: M-DNA 100-bp ladder. Lanes 1–7: RE fragments (758 bp and 315 bp). B) RE
analysis of blaTEM by AvaII. Lane M: Ladder. Lanes 2–8: RE fragments (636 bp, 222 bp, 215 bp). Lane 1: undigested band.

antibiotics. This selective use of a type of cephalosporin
directly would be correlated with the resistance trend to
that antibiotic, as has been reported for pigs treated with
ceftiofur or cefquinome (23).
As per the CLSI (9), cephalosporins like cefpodoxime
(10 µg), ceftazidime (30 µg), cefotaxime (30 µg), and
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ceftriaxone (30 µg) are used for the initial screening
of ESBLs among Klebsiella pneumoniae, K. oxytoca,
and E. coli. For all the ESBL-producing strains, the test
interpretation should be reported as resistant to extendedspectrum cephalosporins including cefixime (5 µg). In the
present study, too, we have recorded the bacterial isolates
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Figure 7. A) RE analysis of blaSHV by PstI. Lane M: 50-bp DNA ladder. Lanes 1–3: RE fragments
(304 bp and 168 bp). Lane 4: Intact product (positive). B) RE analysis of blaSHV by AvaII. Lane M:
50-bp DNA ladder. Lane 1: Intact product (positive). Lanes 2–4: RE fragments (330 bp and 142 bp).

resistant to ceftazidime and cefixime and also observed the
ESBL phenotypic test by combination disk method using
ceftazidime (30 µg) and ceftazidime (30 µg)-clavulanic
acid (10 µg), which is indicative of ESBL production by the
bacterial isolates. These findings on ESBL screening using
the phenotypic methods of the present study are consistent
with previous reports (7,24). Phenotypic detection of
ESBLs and carbapenemases aids in the rapid clinical
diagnosis of resistant bacterial pathogens (24). Bacterial
resistance to amoxicillin-clavulanic acid might be due
to the expression of inhibition-resistant beta-lactamases
from the isolates.
In Enterobacteriaceae, the antimicrobial resistance
genes reside in plasmids. Responding to the selective
pressure of antimicrobials, the plasmids, through functional
expression, protect their hosts (bacteria) (25). The numbers
and sizes of plasmids varied from bacteria in the present
study. Moreover, many bacterial isolates shared a common
plasmid pattern. Similar plasmid profiles with or without
variability among Enterobacteriaceae bacteria have been
reported earlier (26), thus agreeing with the findings of the
present study. We also recorded larger plasmids of >21 kb
in size. The ESBLs, AmpC beta-lactamases, and inhibitorresistant derivatives of TEM and SHV acquire resistance
through large plasmids (27). Furthermore, the similarity
in plasmids among different isolates suggested plasmid
movement between bacteria. However, a variability of
plasmids among bacteria of the same taxonomical groups
indicated their evolution and spread from different niches.

Molecular detection of blaTEM and blaSHV among the
bacterial isolates using PCR could be correlated with the
functional expression of their resistance to the extendedspectrum cephalosporins and by a phenotypic method of
ESBL screening. Coexpression of two or more resistance
genes potentiates the bacterial resistance spectrum against
the antimicrobials of one or more than one class. Similar
coexpression of the blaTEM and blaSHV genes among E.
coli and Klebsiella spp. strains was reported earlier (10),
thus supporting the findings of the present study. More
phenotypic positivity of antimicrobial resistance compared
to the PCR-based detection of ESBL genes in the present
study might be due to the presence of other probable
resistance genes. Among the carbapenem-resistant isolates,
the PCR negativity to the blaKPC or blaNDM gene might be
due to the possibility of other carbapenemases (IMP, VIM,
OXA, CMY, etc.) that could not be targeted in the present
study. The production of cephalosporinase (AmpC-betalactamase and ESBLs have low-level carbapenemase
activity) and porin loss also develops in enterobacteria
resistant to carbapenems (28).
RE analyses of the blaTEM and blaSHV genes indicated the
presence of common restriction sites in DNA fragments
after PstI and AvaII restriction digestion. These results
could be supported by a previous study (10) that reported a
uniform band pattern for blaTEM and blaSHV genes after PstI
digestion, therefore indicating a point source or a common
evolutionary origin of all ESBL isolates. However, two PCR
products representing the blaSHV genes indicated nucleotide
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variation, which suggested that these bacteria might have
acquired the blaSHV alleles from different sources.
Uniformity in nucleotide sequences of the blaTEM gene
in the present study indicated a common structure of
the encoded beta-lactamases. This unaltered amino acid
sequence (computationally translated) of the blaTEM gene
might be due to a redundancy of the genetic code. This
uniformity in blaTEM gene sequences could be correlated
with the findings of a previous study that reported that
bacteria harbor blaTEM-1 as a common blaTEM allele due
to their ﬁtness advantage in the presence of penicillins
(29). Selective pressure due to prolonged consumption
of particular antibiotics might be a possible factor
contributing to the high frequency of the blaSHV gene
subtype. The nonclonal blaSHV gene encoded common
amino acid sequences except glycine (G) at codon position
130 (position 234 from the initiation codon) and glutamic
acid (E) at codon position 131 (position 235 from the
initiation codon) with respect to the computationally
translated protein of 156 amino acids from 468 nucleotides
(out of 472 nucleotides). The presence of different plasmidmediated alleles of the beta-lactamase genes (blaSHV) in
the present study indicated that the plasmids might have
acquired these genes possibly on transposable elements
from different sources (30). An earlier study from
Switzerland showed a high genetic diversity of the ESBL-

harboring bacterial strains of cattle (16). The relatively
high rate of occurrence of diverse ESBL-producing strains
of food animals indicates that there is an established
reservoir of these organisms in farm animals.
In conclusion, this study highlighted the occurrence of
blaTEM- and blaSHV-producing coliform bacteria from cattle.
The presence of ESBL-producing Enterobacteriaceae in
fecal samples of farm animals poses a risk of contaminating
animal food products like meat and milk. It may lead to
colonization of healthy humans with ESBL-producing
bacteria and thus raises urgent needs for advanced
antimicrobial therapy. It is recommended that a monitoring
system be established to analyze the further trends of ESBL
epidemiology in order to restore the efficacy of important
oxyimino cephalosporins for treating the severe infections
of animals and humans. Rapid phenotypic detection of
ESBLs and specific detection of blaTEM and blaSHV genes
by PCR is helpful in limiting the further spread of such
antimicrobial resistant pathogens.
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